Ongoing Disclosure Notice

28 December 2022

NZX releases

Latest NZX releases

View all

12 Sep 2024

Shareholder Letter

Arvida Group Limited has today sent the attached letter to shareholders regarding the proposed Scheme.
11 Sep 2024

SPH Notice - Morgan Stanley and its Subsidiaries

Please see attached a Substantial Product Holder notice for Morgan Stanley and its Subsidiaries listed in Annexure A in ...
10 Sep 2024

SPH Notice - UBS Group AG and its related bodies corporate

Please see attached a Substantial Product Holder notice for UBS Group AG and its related bodies corporate in Arvida Grou...
06 Sep 2024

SPH Notice - Morgan Stanley and its Subsidiaries

Please see attached a Substantial Product Holder notice for Morgan Stanley and its Subsidiaries listed in Annexure A in ...

Your steps to care

Step 3 of 4

Whether you are looking for urgent care or thinking about future needs, we will talk you through the options available in your preferred communities.

3. What is the current status of your loved one?

Need care urgently
Considering care & moving shortly
Looking at options for the future

Your steps to care

Step 4 of 4

If you are unsure about the type of care you require or are yet to have a NASC assessment, it doesn’t matter. We understand the process and can help you through it.

4. Do you know what kind of care you require?

Rest home or Hospital
Dementia
Unsure

Has an assessment being completed by the Needs Assessment and Services Coordinator (NASC)?

Yes
No

Your steps to care

How we can help

Every Arvida Living Well Community has an expert who can work with you to find the right type of personalised care for your needs, whether you need an immediate solution or looking for options that might be needed soon. Explore the communities below, then get in touch with them directly.

Communities that offer these services

Would you like us to send you some info now?

Either get exploring straight away or leave us your details and we will be in touch with you as soon as possible.

You can also call us on 0800 278 432 with any questions.

Name:*

Email:*

Phone:

- Please select your interested community

Any notes?:

Arvida

Ongoing Disclosure Notice

Related documents